Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) is an interferon-inducible immune checkpoint expressed on tumor-infiltrating lymphocytes (TILs). IDO is known as a poor prognostic marker in esophageal squamous cell cancer, while a positive effect was shown for breast cancer. A comprehensive analysis of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Immunol Res
Hlavní autoři: Loeser, Heike, Kraemer, Max, Gebauer, Florian, Bruns, Christiane, Schröder, Wolfgang, Zander, Thomas, Alakus, Hakan, Hoelscher, Arnulf, Buettner, Reinhard, Lohneis, Philipp, Quaas, Alexander
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527882/
https://ncbi.nlm.nih.gov/pubmed/33029538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2862647
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky